TRex Bio Reports Q3 2026 Results, $13.2 Million Net Loss

TRex Bio reported a third-quarter 2026 net loss of $13.2 million, compared with $7.9 million a year earlier, as operating expenses rose. The company reported $78.2 million in cash, cash equivalents and marketable securities at quarter-end and completed an IPO in October that provided approximately…